Synapsoft logo
AI Insights from Disclosures
Searching...
Shaperon Inc. 378800
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Shaperon Inc. is a biotech venture specializing in new drug research and development, holding the world's first new drug development platform targeting GPCR19 to inhibit P2X7-NLRP3 inflammasome activity, as well as a nanobody antibody development platform that can meet the unmet needs of existing bispecific antibody therapeutics and antibody-drug conjugate formulations.
Representative Director Seong Seungyong
Founded October 1, 2008
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 11011-3977050
Business number 101-86-42705
Phone Number 02-6083-8315
Fax Number 02-6083-8318
Website shaperon.com
Company Address 174-10 Jagok-ro, Gangnam-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant